1. Home
  2. CACI vs ICLR Comparison

CACI vs ICLR Comparison

Compare CACI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$469.54

Market Cap

10.3B

Sector

Technology

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$176.68

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
ICLR
Founded
1962
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
9.3B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
CACI
ICLR
Price
$469.54
$176.68
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$689.50
$178.62
AVG Volume (30 Days)
265.1K
1.1M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
N/A
EPS
17.11
N/A
Revenue
$4,467,860,000.00
N/A
Revenue This Year
$12.42
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
$27.26
$12.91
Revenue Growth
2.60
N/A
52 Week Low
$434.70
$66.57
52 Week High
$683.50
$211.00

Technical Indicators

Market Signals
Indicator
CACI
ICLR
Relative Strength Index (RSI) 42.24 76.43
Support Level $434.70 $174.63
Resistance Level $511.94 $193.87
Average True Range (ATR) 19.23 7.72
MACD -2.69 2.28
Stochastic Oscillator 34.68 88.32

Price Performance

Historical Comparison
CACI
ICLR

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: